Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TILT feasibility study of intrapleural OK-432 in mesothelioma
2016-004727-23Phase 2Unknown
- Sponsor
- North Bristol NHS Trust
- Start
- May 2018
- Modality
- Therapeutic Vaccines → Vaccines & Immunotherapeutics, Cell Therapies, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of streptococcus pyogenes preparation in pleural mesothelioma, sponsored by North Bristol NHS Trust. Primary endpoint: Feasibility. Status: unknown.
02
Drugs
streptococcus pyogenes preparation
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on 2016-004727-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004727-23.